Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Anafranil
Generic Name: Clomipramine
See also: Anafranil
A tricyclic antidepressant used to treat people with obsessive-compulsive disorder (OCD). It is also used, off label, in the treatment of depression, panic attacks and pain.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| OCD (Obsessive-Compulsive Disorder) | 18 | 6 |
|
|
|
|
|
| Depressed mood | 10 | 6 |
|
|
|
||
| Treat my mood condition(s) | 9 | 2 |
|
|
|||
| Obsessive thoughts | 8 | 4 |
|
|
|||
| Major Depressive Disorder | 6 | 2 |
|
|
|||
| Other | 4 | 0 |
See all 42 patients currently taking Clomipramine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Clomipramine
| Dry mouth (xerostomia) | 5 | |
|---|---|---|
| Weight gain | 3 | |
| Excessive daytime sleepiness (somnolence) | 2 | |
| Sweating excessive | 2 | |
| Sex drive (libido) decreased | 1 | |
| Confusion | 1 | |
| See all 21 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Clomipramine. See all 11 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 13 | ||
| Side effects too severe | 11 | ||
| Doctor's advice | 9 | ||
| Other | 4 | ||
| Personal research | 1 | ||
| Expense | 1 | ||
| Course of treatment ended | 1 |
Adherence
Taking treatment as prescribed
Adherence of Clomipramine
Always |
15 | 79% |
|
|---|---|---|---|
Usually |
3 | 16% |
|
Sometimes |
0 | 0% |
|
Never |
1 | 5% |
|
Burden
Difficulty being on treatment
Burden of Clomipramine
Very |
1 | 5% |
|
|---|---|---|---|
Somewhat |
3 | 16% |
|
A little |
5 | 26% |
|
Not at all |
10 | 53% |
|
Cost
Paid out of pocket
Cost of Clomipramine
$200+ |
1 | 9% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
2 | 18% |
|
$25-49 |
1 | 9% |
|
< $25 |
7 | 64% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 27, 2012.